Navenibart

· Astria Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Navenibart, covering 2025-11-05 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Navenibart in Participants With Hereditary Angioedema [Phase 3]